Immune events at the blood-brain barrier
The blood brain barrier (BBB) is crucial for proper functioning of our brain. People with progressive MS or Alzheimer’s disease are suffering from a hampered BBB function. To date, the cause of this impaired function is unknown. AUMC, Biolamina, Confocal, Eyesiu, Mimetas, Standard BioTools and UMCG have teamed up in IMM-BBB to generate human models to discover the underlying cause of these diseases.
Worldwide more that 50 million people suffer from neurodegenerative diseases such as dementia and progressive MS. In 2050, this number is expected to increase to 100 million affected people. As a consequence, the healthcare costs of people with neurodegenerative diseases are expected to exceed any other healthcare costs especially in Europe since most day-to-day care is provided by younger family members.
IMM-BBB will use post-mortem material from people with MS and Alzheimer’s disease. In addition, IMM-BBB is able to generate all cell types of the BBB from stem cells of a single person. With this technology two human models will be created. One model in which blood vessel formation will be studied for Alzheimer’s disease. In the second model passage of immune cells across the BBB will be studied for. progressive MS.
The public summary consists of 250 to max. 300 words. The summary is intended for a broad audience with a secondary education language level. In short, the public summary describes the who, what, where, when, why and how of the project. Focus on the core message of the project instead of elaborating on explanations and background information.
